Chemed Corporation (CHE) Earnings
Chemed Corporation is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $5.63. CHE has beaten EPS estimates in 7 of its last 12 reported quarters (average surprise -2.8% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 24, 2026 | $5.30 | $5.65 | +6.6% | $658M | +1.2% |
| Feb 26, 2026 | $7.02 | $6.42 | -8.5% | $639M | -4.0% |
| Jul 29, 2025 | $4.78 | $4.27 | -10.7% | $619M | -2.0% |
| Apr 23, 2025 | $5.55 | $5.63 | +1.4% | $647M | +0.8% |
| Feb 26, 2025 | $6.78 | $6.83 | +0.7% | $640M | +0.6% |
| Jul 24, 2024 | $5.59 | $5.47 | -2.1% | $596M | -0.6% |
| Feb 27, 2024 | $6.25 | $6.60 | +5.6% | $586M | +0.0% |
| Oct 25, 2023 | $4.90 | $5.32 | +8.6% | $565M | +1.1% |
| Jul 26, 2023 | $5.09 | $4.71 | -7.5% | $554M | -1.2% |
| Feb 23, 2023 | $5.32 | $5.39 | +1.3% | $547M | +0.0% |
| Oct 31, 2022 | $4.65 | $4.74 | +1.9% | $526M | -0.1% |
| Jul 27, 2022 | $4.78 | $4.84 | +1.3% | $531M | -1.3% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · April 24, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
VITAS performance exceeded expectations with 2.2% days of care increase and Medicare reimbursement rate increase. Roto-Rooter saw core residential service revenue increase, added 18 new commercial business managers. VITAS added over $32.5 million to cap cushion in Florida combined program. Roto-Rooter acquired franchises in SF and Fort Worth, expected to add $5 - $5.5 billion revenue in 2026.
Guidance
Full year ADC growth for 2026 updated to 4.5% - 5.5% from 3.5% - 4%. Anticipated revenue growth excluding Medicare cap revised to 6.5% - 7.5% from 5.5% - 6.5%. EBITDA margin excluding Medicare cap 18% - 18.5%. Roto-Rooter revenue growth unchanged at 3 - 3.5%, adjusted EBITDA margin 21.5% - 22.5%.
Segment performance
VITAS: Net revenue was $420 million in Q1 2026, up 3.1% y-o-y. Revenue increase due to 2.2% days of care increase and ~2.6% Medicare reimbursement rate increase. Average revenue per day was $210.62. Adjusted EBITDA excluding Medicare cap was $70.8 million, up 0.6% y-o-y, margin 16.8%. Roto-Rooter: Branch commercial revenue $56.5 million, down 1.9% y-o-y. Residential revenue $166.3 million, down 1.5% y-o-y. Adjusted EBITDA $53.5 million, down 9.6% y-o-y, margin 22.5%, down 218 basis points.
Risks & headwinds
Roto-Rooter affected by weather events, Google algorithm changes, independent contractor performance, water restoration price per job issues.
Analyst Q&A
Q: On VITA margins and headcount,
A: Averaged ~100 FTEs below budget, intend to add 60 FTEs per month.
Q: On Roto-Rooter marketing costs,
A: Spent $3 million more in Q1, expect marketing costs to continue.
Q: On Florida cushion and rate update,
A: Rate increase in Florida might be slightly lower than national average, still crunching numbers.